Фамилия: *

Имя: *


Электронный адрес (e-mail): *

Регион: *

Населённый пункт: *

Текст обращения: *

Размер файла не более 5 Мб. Форматы файлов: txt, doc, rtf, xls, pps, ppt, pdf, jpg, bmp, png, tif.
Подтверждаю согласие на обработку и хранение моих персональных данных *

Поля со * обязательны к заполнению


International Panel Discussion “Relevance of medical devices in Value-Based Healthcare projects”

The event was organized by the Biomedical Technologies Cluster, Skolkovo Foundation in collaboration with the Health Technology Assessment Association. Participants discussed issues related to availability of innovative technologies and improvement of medical care quality in the framework of value-based healthcare. The participants included representatives of the Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation, chiefs of professional departments, committees and divisions of the Federal Executive and Constituent authorities of the Russian Federation, representatives of the Federal and regional funds of the Compulsory Health Insurance, representatives of scientific expert communities, members of medical universities, and also representatives of international organizations and leading international experts in health technology assessment and value-based healthcare. Event partners were comprised of Medtronic, Frezenius Medical Care in Russia and Alcon.

First session was moderated by Konstantin Binko, Deputy Director of the Department for Medicines Provision and Regulation of Medical Devices Circulation of the Ministry of Health, which was devoted to regulation of medical devices circulation and pricing, financing and access to innovative technologies in Russia as well as aspects and main obstacles to medical devices procurement. In addition, perspectives of comprehensive assessment of medical devices and risks of their pricing regulation were discussed.

Igor Kazmin, Deputy Director of the National Institute of Quality of the Federal Service for Surveillance in Healthcare, delivered a talk on “Approaches to development of a catalogue of goods, works and services for state and municipal needs in relation to medical devices”. In his speech it was noted that a catalogue of goods, works and services for state and municipal needs is undoubtedly a unique, emerging and effective tool which allows to control and simplify state procurement procedures through collaboration and coordination of electronic systems of the various federal executive bodies.

Nuriya Musina, Chief of Development and Communications of the Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation, emphasized the necessity to adopt comprehensive assessment for high-cost medical devices, such as implantable ones, and to develop methodology on comprehensive assessment in accordance with medical devices characteristics but of course considering gained experience in comprehensive assessment of drugs.

“It is of great importance to conduct joint events here in Skolkovo. We are taking actions to contribute to technology entrepreneurship development by offering Skolkovo residents in different regions of Russia various ways of support such as acceleration and educational programs, mentorship, possibility to participate in Russian and international forums”, said the  Director for Acceleration of Biomedical Technologies Cluster, Skolkovo Foundation, Anton Pavlyukov.

The second session was moderated by Vitaly Omelyanovskiy, General Director of the Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation. The session was focused on the Value-Based Healthcare (VBH), which is being actively adopted in health systems in developed countries. The question of Russian health system being ready to adopt this new concept was also raised. VBH holds a lot of potential to improve medical care quality in combination with adoption of differentiated approach to its payment. VBH is based on the relation between treatment costs and patient outcomes. All in all, experts discussed VBH concept and main stages, challenges and risks for its adoption, and also analyzed examples of public-private partnership in VBH. Russian and foreign experts shared their experience and examples of VBH adoption in Russia and Europe.

The Head of Department for Medical Standardization of the Center for Healthcare Quality Assessment and Control of the Ministry of Health, Olga Suhorukikh, talked about current medical care control system and development of criteria for medical care quality assessment. It was also noted that current control system does not allow to evaluate core VBH elements, i.e. disease management and patient outcomes, although it is effective in terms of a possible transition to the value-based healthcare.

Roman Gostischev, Deputy Chief Medical Officer for Prospective Development of the City Clinical Hospital №40 of Moscow Healthcare Department, pointed out that relevant criteria for VBH to be adopted in Russia are: 1) organization of centers of excellence for particular nosologies involving corresponding specialists to promote patient-centered medical care; 2) development of VBH projects within medical organizations, which would provoke competition between physicians and consequently improve medical care quality.

Lucas Scherdel, Project Lead, Global Coalition Value in Healthcare World Economic Forum delivered a talk on Public-Private partnership in Value-Based Healthcare. He emphasized that public-private partnership would accelerate value-based healthcare concept transformation through additional financing and new models, improving outcomes and reducing overall costs.

Foreign experts, Ralph van Aken and Christian Apel, were invited to participate in the panel discussion to share value-based healthcare projects for diabetes and renal care.